Results 121 to 130 of about 19,575,590 (338)
Epidemiology of chronic kidney disease: an update 2022.
Kidney international. Supplement, 2022 C. Kovesdy
semanticscholar +1 more source
Religious Identities in Southeastern Europe: Pomaks in Greece and Bulgaria: Behind the State Valance
, 2017 First, I will briefly explain the important events that have coincided or strongly influenced Pomak identity during the twentieth century. Several Greek and Bulgarian state policies will be mentioned for they served as fierce attempts to essentially ...
Ubiparipović, Stefan
core
Next‐generation proteomics improves lung cancer risk prediction
Molecular Oncology, EarlyView.This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
BMC Complementary Medicine and TherapiesBackground The treatment of severe bleeding, stopping pregnancies, and other gynecologic conditions have all been addressed by women using traditional medicines and methods.
Alemnew Wale +3 more
doaj +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
Molecular Oncology, EarlyView.WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
RWW 2022 Workshops [RWW 2022] [PDF]
IEEE Microwave Magazine, 2021 Vaclav Valenta, Venkata Vanukuru
openaire +1 more source
Molecular Oncology, EarlyView.Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source